China's securities regulator on Saturday released draft prospectuses for a small group of companies planning to list, in a move that may soothe investor concerns that the country had put in place a de facto freeze on IPOs.

The 28 prospectuses, published on the website of the China Securities Regulatory Commission (CSRC), included Well Lead Medical, a medical equipment firm in the southern city of Guangzhou, and Hangzhou Weiguang Electronic Co Ltd, which makes motors for electric fans.

But it is unclear whether, or when, the companies will be approved to list.

Sixteen of the companies on the list are applying for the main board of the Shanghai Stock Exchange, eight for the ChiNext Board and four for Shenzhen's small- and medium-sized enterprises board.

The CSRC told investors last week that China had not closed its window for IPO applications.

No new companies have listed for nearly two months, leading Chinese media to speculate that an informal freeze is in place.

China allowed initial public offerings to resume in early 2014 after a hiatus of 14 months, allowing around 50 already approved companies to list on the Shanghai and Shenzhen exchanges.

More than 600 companies are still in the queue.

Related Articles

锦天城、嘉源助力“扫描全能王”母公司登陆科创板(ZH/EN)

中国人工智能、大数据企业合合信息在上交所科创板成功上市,募资13.8亿元。锦天城律师事务所为发行人提供服务,嘉源律师事务所则担任保荐机构中金公司的法律顾问。

嘉源、金杜、世辉等领衔美的集团超300亿港元IPO(ZH/EN)

中国家电巨头美的集团在香港联交所主板成功上市,募资额超过300亿港元。这是自2021年快手登陆港交所以来、3年多时间内最大的港股IPO项目;也是今年全球规模第二大的IPO。

中伦、君合等牵头香港第二宗18C章上市项目(ZH/EN)

智能汽车芯片公司黑芝麻智能在香港联交所主板成功上市。发行人方面,中伦律师事务所担任中国律师,高伟绅律师事务所担任香港及美国律师,高盖茨律师事务所就美国出口管制法律提供意见;保荐人方面,君合律师事务所担任中国律师,美国威尔逊律师事务所担任香港及美国律师。